sec filing
GC
NASDAQ · GCTK
GlucoTrack, Inc.
Healthcare · Medical - Instruments & Supplies
$3.23
Up+$0.09 (+2.87%)
Updated Sep 11, 2026, 6:26 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 3.34M
- P/E ratio
- -0.66
- Dividend yield
- 0.00%
- 52-week range
- $0.25 – $5.25
- Volume
- 17.7K
- Avg. volume
- 1.24M
Price performance
GCTK price history
1M range · 20 trading sessions · Daily adjusted prices
GCTK closed at $3.23 after 20 trading sessions, up 783.72% for the selected period.
- Last close
- $3.23
- Period change
- +783.72%
- Period low
- $0.33
- Period high
- $5.10
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $3.04 | $3.23 | $3.04 | $3.23 | 17.7K |
| Sep 9, 2026 | $2.93 | $3.2998 | $2.93 | $3.14 | 59.01K |
| Sep 8, 2026 | $3.03 | $3.11 | $2.90 | $2.93 | 36.08K |
| Sep 4, 2026 | $3.26 | $3.31 | $2.95 | $2.98 | 75K |
| Sep 3, 2026 | $3.56 | $3.646 | $3.29 | $3.32 | 47.71K |
| Sep 2, 2026 | $3.49 | $3.9799 | $3.49 | $3.53 | 62.04K |
| Sep 1, 2026 | $4.08 | $4.27 | $3.675 | $3.68 | 77.69K |
| Aug 31, 2026 | $4.20 | $4.36 | $4.00 | $4.25 | 153.8K |
| Aug 28, 2026 | $4.20 | $4.332 | $4.185 | $4.23 | 178.67K |
| Aug 27, 2026 | $5.022 | $5.022 | $4.2375 | $4.293 | 112.86K |
| Aug 26, 2026 | $5.16 | $5.247 | $4.7295 | $4.8165 | 38.31K |
| Aug 25, 2026 | $5.10 | $5.103 | $4.95 | $5.103 | 37.48K |
| Aug 24, 2026 | $0.337 | $0.345 | $0.33 | $0.3324 | 224.48K |
| Aug 21, 2026 | $0.3378 | $0.3698 | $0.3303 | $0.3474 | 697.6K |
| Aug 20, 2026 | $0.3469 | $0.35 | $0.3302 | $0.3416 | 532.41K |
| Aug 19, 2026 | $0.3318 | $0.3545 | $0.33 | $0.3488 | 428.99K |
| Aug 18, 2026 | $0.34 | $0.3549 | $0.3067 | $0.345 | 1.47M |
| Aug 17, 2026 | $0.3901 | $0.4049 | $0.333 | $0.342 | 23.85M |
| Aug 14, 2026 | $0.367 | $0.389 | $0.365 | $0.3674 | 639.99K |
| Aug 13, 2026 | $0.369 | $0.4041 | $0.3618 | $0.3655 | 1.16M |
Latest GCTK news
The latest Smart Investors Daily articles mentioning GCTK.
Stock researchCompany · Financials
Loading stock research…